11-HDoHE

Metabolite details

Identifier

LTERDCBCHFKFRI-BGKMTWLOSA-N

InChI Key

LTERDCBCHFKFRI-BGKMTWLOSA-N

IUPAC name

(4Z,7Z,9E,13Z,16Z,19Z)-11-hydroxydocosa-4,7,9,13,16,19-hexaenoic acid

Preferred name

11-HDoHE

INN name

—

Synonym

(±)-11-HDoHE

ChEBI

CHEBI:72794

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
• Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
• Lipid mediators of inflammation in BALF 3-13 days after infection with influenza.
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates

Observed in differential profiles

• Mock_19d_vs_PR8_19d
• G1_Mock_11_day_vs_G5_PR8_11_day
• Mock_13d_vs_PR8_13d
• Control_vs_ZYP_High_Dose
• Control_Liver_vs_Treatment_Liver